Total Homocysteine is Associated with White Matter Hyperintensity Volume: the Northern Manhattan Study

Overview

Journal Stroke

Specialties Cardiology & Vascular Diseases
Neurology

Date 2005 May 10

PMID 15879345

Citations 85

Authors

Clinton B Wright

Myunghee C Paik

Truman R Brown

Sally P Stabler

Robert H Allen

Ralph L Sacco

Charles DeCarli

Affiliations

Soon will be listed here.

Abstract

Background: Total homocysteine (tHcy) has been implicated as a risk factor for stroke and dementia, but the mechanism is unclear. White matter hyperintensities may be a risk factor for both, but studies of the relationship between tHcy and quantitative measures of white matter hyperintensity volume (WMHV) are lacking, especially in minority populations.

Methods: A community-based sample of 259 subjects with baseline tHcy levels underwent pixel-based quantitative measurement of WMHV. We examined the relationship between tHcy and WMHV adjusting for age, sociodemographics, vascular risk factors, and B12 deficiency.

Results: Higher levels of tHcy were associated with WMHV adjusting for sociodemographics and vascular risk factors.

Conclusions: These cross-sectional data provide evidence that tHcy is a risk factor for white matter damage.

Citing Articles

Cortical lobar volume reductions associated with homocysteine-related subcortical brain atrophy and poorer cognition in healthy aging.

Song H, Bharadwaj P, Raichlen D, Habeck C, Grilli M, Huentelman M Front Aging Neurosci. 2024; 16:1406394.

PMID: 39170895 PMC: 11335513. DOI: 10.3389/fnagi.2024.1406394.

Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities.

Huang W, Lin Q, Tzeng C J Stroke. 2024; 26(2):131-163.

PMID: 38836265 PMC: 11164597. DOI: 10.5853/jos.2023.02719.

Effect of dietary protein intake on cognitive function in the elderly with chronic kidney disease: analysis of the National Health and Nutrition Examination Survey 2011-2014.

Huang J, Yu Y, Li H, Wei Y, Sun M Ren Fail. 2023; 45(2):2294147.

PMID: 38097960 PMC: 10732213. DOI: 10.1080/0886022X.2023.2294147.

Changes in the glymphatic system before and after dialysis initiation in patients with end-stage kidney disease.

Lee Y, Park K, Heo C, Park S, Kim Y, Lee D Ren Fail. 2023; 45(2):2265665.

PMID: 37795782 PMC: 10557553. DOI: 10.1080/0886022X.2023.2265665.

Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes.

Weekman E, Johnson S, Rogers C, Sudduth T, Xie K, Qiao Q J Neuroinflammation. 2023; 20(1):199.

PMID: 37658433 PMC: 10474691. DOI: 10.1186/s12974-023-02883-x.

References

Breteler M, van Swieten J, Bots M, Grobbee D, Claus J, van den Hout J . Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994; 44(7):1246-52. DOI: 10.1212/wnl.44.7.1246. View

DeCarli C, Murphy D, Tranh M, Grady C, Haxby J, Gillette J . The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995; 45(11):2077-84. DOI: 10.1212/wnl.45.11.2077. View

Longstreth Jr W, Manolio T, Arnold A, Burke G, Bryan N, Jungreis C . Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996; 27(8):1274-82. DOI: 10.1161/01.str.27.8.1274. View

Breteler M, Claus J, Grobbee D, Hofman A . Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994; 308(6944):1604-8. PMC: 2540432. DOI: 10.1136/bmj.308.6944.1604. View

Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F . Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993; 43(9):1683-9. DOI: 10.1212/wnl.43.9.1683. View

Ueland P, Refsum H, Stabler S, MALINOW M, Andersson A, Allen R . Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993; 39(9):1764-79. View

DeCarli C, Maisog J, Murphy D, Teichberg D, Rapoport S, Horwitz B . Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr. 1992; 16(2):274-84. DOI: 10.1097/00004728-199203000-00018. View

van Swieten J, GEYSKES G, Derix M, Peeck B, Ramos L, van Latum J . Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991; 30(6):825-30. DOI: 10.1002/ana.410300612. View

van Swieten J, van den Hout J, van Ketel B, Hijdra A, Wokke J, van Gijn J . Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991; 114 ( Pt 2):761-74. DOI: 10.1093/brain/114.2.761. View

10.

Stabler S, Marcell P, Podell E, Allen R . Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem. 1987; 162(1):185-96. DOI: 10.1016/0003-2697(87)90026-1. View

11.

Sacco R, Anand K, Lee H, Boden-Albala B, Stabler S, Allen R . Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke. 2004; 35(10):2263-9. DOI: 10.1161/01.STR.0000142374.33919.92. View

12.

Jeerakathil T, Wolf P, Beiser A, Massaro J, Seshadri S, DAgostino R . Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004; 35(8):1857-61. DOI: 10.1161/01.STR.0000135226.53499.85. View

13.

Wright C, Lee H, Paik M, Stabler S, Allen R, Sacco R . Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology. 2004; 63(2):254-60. PMC: 1352321. DOI: 10.1212/01.wnl.0000129986.19019.5d. View

14.

Sachdev P, Parslow R, Salonikas C, Lux O, Wen W, Kumar R . Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch Neurol. 2004; 61(9):1369-76. DOI: 10.1001/archneur.61.9.1369. View

15.

Schmidt R, Launer L, Nilsson L, Pajak A, Sans S, Berger K . Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes. 2004; 53(3):687-92. DOI: 10.2337/diabetes.53.3.687. View

16.

Hassan A, Hunt B, OSullivan M, Bell R, DSouza R, Jeffery S . Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2003; 127(Pt 1):212-9. DOI: 10.1093/brain/awh023. View

17.

Vermeer S, Hollander M, van Dijk E, Hofman A, Koudstaal P, Breteler M . Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003; 34(5):1126-9. DOI: 10.1161/01.STR.0000068408.82115.D2. View

18.

Dufouil C, Alperovitch A, Ducros V, Tzourio C . Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol. 2003; 53(2):214-21. DOI: 10.1002/ana.10440. View

19.

Wong T, Klein R, Sharrett A, Couper D, Klein B, Hubbard L . Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002; 288(1):67-74. DOI: 10.1001/jama.288.1.67. View

20.

Vermeer S, van Dijk E, Koudstaal P, Oudkerk M, Hofman A, Clarke R . Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002; 51(3):285-9. DOI: 10.1002/ana.10111. View